Get this delivered to your inbox, and more info about our products and services.
The charts are showing this biotech stock can strengthen into year-end
David Keller breaks down the technicals on this biotech giant.
14 words~1 min read
Related reading
This biotech stock could see a sharp swing higher after years of struggling,…
Chart analyst Frank Cappelleri breaks down the technical outlook on the biotech stock.
There's a 'bearish-to-bullish' reversal happening in this biotech stock, says…
Carter Worth breaks down the charts on this biotech stock.
A bullish breakout in this little-known pharma stock is forming, charts show
Frank Cappelleri of CappThesis breaks down the bullish technical backdrop for this pharma-related stock.
This biotech made it through a 'time correction.' The charts say it could be…
David Keller breaks down the charts on Incyte Corp.
The charts on this telehealth stock point to strong gains ahead, according to…
Katie Stockton breaks down the technical outlook on this telehealth name.
Breaking down the charts on this outperforming medical device maker
Chart analyst Frank Cappelleri goes through the charts that make this stock an attractive play.